TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
鄭惠禎Cheng, Hui-Chen
- 協同主持人
- 執行臨床試驗年資
-
hccheng7@vghtpe.gov.tw
發表文獻
27筆
11
Cheng HC, Huang TL, Lin KJ, et al. Summary of the Neuro-ophthalmology Symposium in the 31st Asia-Pacific Academy of Ophthalmology Congress (APAO 2016). Neuro-ophthalmology 2016;40:251-3.
12
Cheng HC, Yeh HJ, Huang N, Wang AG. Reply. Ophthalmology 2016;123:e59-60.
13
Cheng HC, Pan RH, Yeh HJ, Lai KR, Yen MY, Chan CL, et al. Ambient Air Pollution and the Risk of Central Retinal Artery Occlusion. Ophthalmology. 2016;123(12):2603-9.
14
Wang AG, Cheng HC. Amiodarone-Associated Optic Neuropathy: Clinical Review. Neuro-ophthalmology 2017;41:55-8.
15
Kuo YS, Liu CJ, Cheng HC, et al. Impact of socioeconomic status on vision-related quality of life in primary open-angle glaucoma. Eye (Lond) 2017;31:1480-7.
16
Lee CW, Cheng HC, Chang FC, Wang AG. Optical Coherence Tomography Angiography Evaluation of Retinal Microvasculature Before and After Carotid Angioplasty and Stenting. Sci Rep 2019;9:14755.
17
Lu YT, Lu YC, Cheng HC, et al. Chronic rhinosinusitis after radiotherapy in patients with head and neck cancer: a population-based cohort study in Taiwan. Int Forum Allergy Rhinol 2020;10:692-7.
18
Lo KJ, Wang AG, Cheng HC*. Retinal Vasculature Changes after Bypass Surgery for Moyamoya Disease. Ophthalmology 2021;128:120.(*corresponding author)
19
Lo KJ, Yang JH, Cheng HC, Chang HY, Lin TC, Recovery of visual field defects following vitrectomy for proliferative diabetic retinopathy. Medicine 2021; 100(48):e27793
20
Chiou YR, Cheng HC, Wang AG. Astrocytic hamartoma in a patient heterozygous for RIM1 mutation associated-retinal dystrophy. Ophthalmic Genet 2022:1-4.
